Republican Steve Daines, a recipient of substantial campaign contributions from the pharmaceutical industry donors, backed a bipartisan drug price control bill. Now he’s behind a GOP plan.
Why Democrats Should Be Most Worried About Troy Jackson (And It’s Not the Consultants)
Maine’s Democratic Senate nominee has a weakness in today’s throw-the-bums-out environment—a long record in state government.
Keep reading
by Bill Scher

